SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-052940
Filing Date
2024-04-26
Accepted
2024-04-26 16:13:01
Documents
13
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2412013d1_10ka.htm   iXBRL 10-K/A 431411
  Complete submission text file 0001104659-24-052940.txt   707536

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20231231.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20231231_lab.xml EX-101.LAB 36884
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20231231_pre.xml EX-101.PRE 24142
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2412013d1_10ka_htm.xml XML 6408
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37977 | Film No.: 24883889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)